Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Michael Slifker
PROVIDER: E-GEOD-29917 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Ariazi Eric A EA Cunliffe Heather E HE Lewis-Wambi Joan S JS Slifker Michael J MJ Willis Amanda L AL Ramos Pilar P Tapia Coya C Kim Helen R HR Yerrum Smitha S Sharma Catherine G N CG Nicolas Emmanuelle E Balagurunathan Yoganand Y Ross Eric A EA Jordan V Craig VC
Proceedings of the National Academy of Sciences of the United States of America 20111019 47
In laboratory studies, acquired resistance to long-term antihormonal therapy in breast cancer evolves through two phases over 5 y. Phase I develops within 1 y, and tumor growth occurs with either 17β-estradiol (E(2)) or tamoxifen. Phase II resistance develops after 5 y of therapy, and tamoxifen still stimulates growth; however, E(2) paradoxically induces apoptosis. This finding is the basis for the clinical use of estrogen to treat advanced antihormone-resistant breast cancer. We interrogated E( ...[more]